Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 163 results.
User Information
Export Records
  1. 1.   Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models
  2. Teuscher, Kevin B; Chowdhury, Somenath; Meyers, Kenneth M; Tian, Jianhua; Sai, Jiqing; Van Meveren, Mayme; South, Taylor M; Sensintaffar, John L; Rietz, Tyson A; Goswami, Soumita; Wang, Jing; Grieb, Brian C; Lorey, Shelly L; Howard, Gregory C; Liu, Qi; Moore,Bill; Stott,Gordon; Tansey, William P; Lee, Taekyu; Fesik, Stephen W
  3. Proceedings of the National Academy of Sciences of the United States of America. 2023, Jan 03; 120(1): e2211297120.
  1. 2.   Locking and Unlocking Thrombin Function Using Immunoquiescent Nucleic Acid Nanoparticles with Regulated Retention In Vivo
  2. Ke, Weina; Chandler, Morgan; Cedrone,Edward; Saito, Renata F; Rangel, Maria Cristina; de Souza Junqueira, Mara; Wang, Jian; Shi, Da; Truong, Nguyen; Richardson, Melina; Rolband, Lewis A; Dréau, Didier; Bedocs, Peter; Chammas, Roger; Dokholyan, Nikolay V; Dobrovolskaia,Marina; Afonin, Kirill A
  3. Nano Letters. 2022, Jul 05;
  1. 3.   Cytokines: From Clinical Significance to Quantification
  2. Liu, Chao; Chu, Dewei; Kalantar-Zadeh, Kourosh; George, Jacob; Young,Howard; Liu, Guozhen
  3. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2021, Jun 10;
  1. 4.   Design and Implementation of the Pre-Clinical DICOM Standard in Multi-Cohort Murine Studies
  2. Kalen,Joseph; Clunie, David A.; Liu,Yanling; Tatum, James L.; Jacobs, Paula M.; Kirby,Justin; Freymann,John; Wagner,Ulli; Smith, Kirk E.; Suloway, Christian; Doroshow, James H.
  3. Tomography. 2021, Mar; 7(1): 1-9.
  1. 5.   Adaptive in vivo device for theranostics of inflammation: real-time monitoring of interferon-? and aspirin
  2. Cao, Chaomin; Jin, Ronghua; Wei, Hui; Liu, Zhongning; Ni, Shengnan; Liu, Guo-Jun; Young,Howard; Chen, Xin; Liu, Guozhen
  3. Acta biomaterialia. 2020, Jan 1; 101: 372-383.
  1. 6.   Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies
  2. Dobrovolskaia,Marina
  3. Molecules (Basel, Switzerland). 2019, Dec; 24(24):
  1. 7.   The "Topological Train Ride" of a Viral Long Non-Coding RNA
  2. Sztuba-Solinska, Joanna; Legrice, Stuart
  3. RNA Biology. 2018, Jan 02; 15(1): 13-16.
  1. 8.   Antiangiogenic and antitumor activity of LP-261, a novel oral tubulin binding agent, alone and in combination with bevacizumab
  2. Gardner, E. R.; Kelly, M.; Springman, E.; Lee, K. J.; Li, H. Q.; Moore, W.; Figg, W. D.
  3. Investigational New Drugs. 2012, Feb; 30(1): 90-97.
  1. 9.   Anti-tumor efficacy of naked siRNAs for ERBB3 or AKT2 against lung adenocarcinoma cell xenografts
  2. Sithanandam, G.; Fornwald, L. W.; Fields, J. R.; Morris, N. L.; Anderson, L. M.
  3. International Journal of Cancer. 2012, Jan; 130(2): 251-258.
  1. 10.   One-pot synthesis and biological evaluation of 2-pyrrolidinyl-4-amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)thiazole: A unique, highly active antimicrotubule agent
  2. Romagnoli, R.; Baraldi, P. G.; Cara, C. L.; Salvador, M. K.; Bortolozzi, R.; Basso, G.; Viola, G.; Balzarini, J.; Brancale, A.; Fu, X. H.; Li, J.; Zhang, S. Z.; Hamel, E.
  3. European Journal of Medicinal Chemistry. 2011, Dec; 46(12): 6015-6024.
  1. 11.   Bioluminescent imaging study FAK inhibitor, PF-562,271, preclinical study in PC3M-luc-C6 local implant and metastasis xenograft models
  2. Sun, H. H.; Pisle, S.; Gardner, E. R.; Figg, W. D.
  3. Cancer Biology & Therapy. 2010, Jul; 10(1): 38-43.
  1. 12.   Biological Assessment of Triazine Dendrimer: Toxicological Profiles, Solution Behavior, Biodistribution, Drug Release and Efficacy in a PEGylated, Paclitaxel Construct
  2. Lo, S. T.; Stern, S.; Clogston, J. D.; Zheng, J. W.; Adiseshaiah, P. P.; Dobrovolskaia, M.; Lim, J. D.; Patri, A. K.; Sun, X. K.; Simanek, E. E.
  3. Molecular Pharmaceutics. 2010, Jul-Aug; 7(4): 993-1006.
  1. 13.   Understanding the Design Principles of Living Systems at the Nanoscale
  2. Jacobs, A.; Blumenthal, R.
  3. Current Nanoscience. 2009 5(1): 45-50.
  1. 14.   Therapeutic Vulnerability of an In Vivo Model of Alveolar Soft Part Sarcoma (ASPS) to Antiangiogenic Therapy
  2. Vistica, D. T.; Hollingshead, M.; Borgel, S. D.; Kenney, S.; Stockwin, L. H.; Raffeld, M.; Schrump, D. S.; Burkett, S.; Stone, G.; Butcher, D. O.; Shoemaker, R. H.
  3. Journal of Pediatric Hematology Oncology. 2009 31(8): 561-570.
  1. 15.   Multicopy plasmid modification with phage lambda red recombineering
  2. Thomason, L. C.; Costantino, N.; Shaw, D. V.; Court, D. L.
  3. Plasmid. 2007, Sep; 58(2): 148-158.
  1. 16.   IL-15 induces C4+ effector memory T cell production and tissue emigration in nonhuman primates
  2. Picker, L. J.; Reed-Inderbitzin, E. F.; Hagen, S. I.; Edgar, J. B.; Hansen, S. G.; Legasse, A.; Planer, S.; Piatak, M.; Lifson, J. D.; Maino, V. C.; Axthelm, M. K.; Villinger, F.
  3. Journal of Clinical Investigation. 2006, JUN; 116(6): 1514-1524.
  1. 17.   Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors
  2. Khan, T.; Stauffer, J. K.; Williams, R.; Hixon, J. A.; Salcedo, R.; Lincoln, E.; Back, T. C.; Powell, D.; Lockett, S.; Arnold, A. C.; Sayers, T. J.; Wigginton, J. M.
  3. Journal of Immunology. 2006, MAY 15; 176(10): 6302-6312.
  1. 18.   gamma-cleavage-independent functions of presenilin, nicastrin, and aph-1 regulate cell-junction organization and prevent tau toxicity in vivo
  2. Doglio, L. E.; Kanwar, R.; Jackson, G. R.; Perez, M.; Avila, J.; Dingwal, C.; Dotti, C. G.; Fortini, M. E.; Feiguin, F.
  3. Neuron. 2006, MAY 4; 50(3): 359-375.
  1. 19.   Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation
  2. Berthet, C.; Klarmann, K. D.; Hilton, M. B.; Suh, H. C.; Keller, J. R.; Kiyokawa, H.; Kaldis, P.
  3. Developmental Cell. 2006, MAY; 10(5): 563-573.
  1. 20.   Generation and characterization of telomere length maintenance in tankyrase 2-deficient mice
  2. Chiang, Y. J.; Nguyen, M. L.; Gurunathan, S.; Kaminker, P.; Tessarollo, L.; Campisi, J.; Hodes, R. J.
  3. Molecular and Cellular Biology. 2006, MAR; 26(6): 2037-2043.
  1. 21.   Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: Functional similarity to the human disease and identification of prospective tumoral markers and targets
  2. Urzua, U.; Roby, K. F.; Gangi, L. M.; Cherry, J. M.; Powell, J. I.; Munroe, D. J.
  3. Journal of Cellular Physiology. 2006, MAR; 206(3): 594-602.
  1. 22.   Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration
  2. Melcon, G.; Kozlov, S.; Cutler, D. A.; Sullivan, T.; Hernandez, L.; Zhao, P.; Mitchell, S.; Nader, G.; Bakay, M.; Rottman, J. N.; Hoffman, E. P.; Stewart, C. L.
  3. Human Molecular Genetics. 2006, FEB 15; 15(4): 637-651.
  1. 23.   IL-3-mediated TNF production is necessary for mast cell development
  2. Wright, H. V.; Bailey, D.; Kashyap, M.; Kepley, C. L.; Drutskaya, M. S.; Nedospasov, S. A.; Ryan, J. J.
  3. Journal of Immunology. 2006, FEB 15; 176(4): 2114-2121.
  1. 24.   Integration of digital signal processing technologies with pulsed electron paramagnetic resonance imaging
  2. Pursley, R. H.; Salem, G.; Devasahayam, N.; Subramanian, S.; Koscielniak, J.; Krishna, M. C.; Pohida, T. J.
  3. Journal of Magnetic Resonance. 2006, FEB; 178(2): 220-227.
  1. 25.   Therapeutic modulation of Akt activity and antitumor efficacy of interleukin-12 against orthotopic murine neuroblastoma
  2. Khan, T.; Hixon, J. A.; Stauffer, J. K.; Lincoln, E.; Back, T. C.; Brenner, J.; Lockett, S.; Nagashima, K.; Powell, D.; Wigginton, J. M.
  3. Journal of the National Cancer Institute. 2006, FEB 1; 98(3): 190-202.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel